Literature DB >> 22410203

Quantifying motion for pancreatic radiotherapy margin calculation.

Gillian Whitfield1, Pooja Jain, Melanie Green, Gillian Watkins, Ann Henry, Julie Stratford, Ali Amer, Thomas Marchant, Christopher Moore, Patricia Price.   

Abstract

BACKGROUND AND
PURPOSE: Pancreatic radiotherapy (RT) is limited by uncertain target motion. We quantified 3D patient/organ motion during pancreatic RT and calculated required treatment margins.
MATERIALS AND METHODS: Cone-beam computed tomography (CBCT) and orthogonal fluoroscopy images were acquired post-RT delivery from 13 patients with locally advanced pancreatic cancer. Bony setup errors were calculated from CBCT. Inter- and intra-fraction fiducial (clip/seed/stent) motion was determined from CBCT projections and orthogonal fluoroscopy.
RESULTS: Using an off-line CBCT correction protocol, systematic (random) setup errors were 2.4 (3.2), 2.0 (1.7) and 3.2 (3.6)mm laterally (left-right), vertically (anterior-posterior) and longitudinally (cranio-caudal), respectively. Fiducial motion varied substantially. Random inter-fractional changes in mean fiducial position were 2.0, 1.6 and 2.6mm; 95% of intra-fractional peak-to-peak fiducial motion was up to 6.7, 10.1 and 20.6mm, respectively. Calculated clinical to planning target volume (CTV-PTV) margins were 1.4 cm laterally, 1.4 cm vertically and 3.0 cm longitudinally for 3D conformal RT, reduced to 0.9, 1.0 and 1.8 cm, respectively, if using 4D planning and online setup correction.
CONCLUSIONS: Commonly used CTV-PTV margins may inadequately account for target motion during pancreatic RT. Our results indicate better immobilisation, individualised allowance for respiratory motion, online setup error correction and 4D planning would improve targeting.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22410203     DOI: 10.1016/j.radonc.2012.02.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

Review 1.  Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Authors:  Falk Roeder
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

2.  Markerless Pancreatic Tumor Target Localization Enabled By Deep Learning.

Authors:  Wei Zhao; Liyue Shen; Bin Han; Yong Yang; Kai Cheng; Diego A S Toesca; Albert C Koong; Daniel T Chang; Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

3.  Assessment with cone-beam computed tomography of intrafractional motion and interfractional position changes of resectable and borderline resectable pancreatic tumours with implanted fiducial marker.

Authors:  Shingo Ohira; Masaru Isono; Yoshihiro Ueda; Takero Hirata; Reiko Ashida; Hidenori Takahashi; Masayoshi Miyazaki; Masaaki Takashina; Masahiko Koizumi; Teruki Teshima
Journal:  Br J Radiol       Date:  2017-03-03       Impact factor: 3.039

4.  Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Authors:  Agata I Rembielak; Pooja Jain; Andrew S Jackson; Melanie M Green; Gillian R Santorelli; Gillian A Whitfield; Adrian Crellin; Angel Garcia-Alonso; Ganesh Radhakrishna; James Cullen; M Ben Taylor; Ric Swindell; Catharine M West; Juan Valle; Azeem Saleem; Patricia M Price
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

5.  Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.

Authors:  Haoming Qiu; Aaron T Wild; Hao Wang; Elliot K Fishman; Ralph H Hruban; Daniel A Laheru; Rachit Kumar; Amy Hacker-Prietz; Richard Tuli; Erik Tryggestad; Richard D Schulick; John L Cameron; Barish H Edil; Timothy M Pawlik; Christopher L Wolfgang; Joseph M Herman
Journal:  Radiother Oncol       Date:  2012-08-08       Impact factor: 6.280

6.  Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

Authors:  Tobin Strom; Sarah E Hoffe; William Fulp; Jessica Frakes; Domenico Coppola; Gregory M Springett; Mokenge P Malafa; Cynthia L Harris; Steven A Eschrich; Javier F Torres-Roca; Ravi Shridhar
Journal:  Radiother Oncol       Date:  2015-07-30       Impact factor: 6.280

7.  Four-Dimensional Magnetic Resonance Imaging With 3-Dimensional Radial Sampling and Self-Gating-Based K-Space Sorting: Early Clinical Experience on Pancreatic Cancer Patients.

Authors:  Wensha Yang; Zhaoyang Fan; Richard Tuli; Zixin Deng; Jianing Pang; Ashley Wachsman; Robert Reznik; Howard Sandler; Debiao Li; Benedick A Fraass
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-08-21       Impact factor: 7.038

Review 8.  Particle therapy of moving targets-the strategies for tumour motion monitoring and moving targets irradiation.

Authors:  Tomasz Kubiak
Journal:  Br J Radiol       Date:  2016-07-19       Impact factor: 3.039

9.  Endobiliary Stent Position Changes during External-beam Radiotherapy.

Authors:  Kwun-Ye Chu; Cynthia L Eccles; Thomas B Brunner
Journal:  J Med Imaging Radiat Sci       Date:  2015-03

10.  Adequacy of inhale/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT.

Authors:  Wensha Yang; Benedick A Fraass; Robert Reznik; Nicholas Nissen; Simon Lo; Laith H Jamil; Kapil Gupta; Howard Sandler; Richard Tuli
Journal:  Radiat Oncol       Date:  2014-01-09       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.